Weight management is not one-size-fits-all
Doctors who Science News talked to for this story emphasized the significance of the recent MASH progress, calling this era in the field a watershed moment, and the more than a dozen new medications in development a tidal wave. Rezdiffra may have been the first drug FDA-approved for MASH, but in the next two to three years, Su says, there will be many more
Before propensity score matching, the semaglutide or tirzepatide cohort and other GLP-1RA cohorts included 82 972 and 124 908 patients, respectively
Zhou Z, Hong EJ, Cohen S, Zhao W-N, Ho H-YH, Schmidt L, et al
Adherence and Education: Ensuring you understand how to properly administer your medication and adhere to your schedule
Book with one of our specialists now